1. Home
  2. SHPH vs ORIS Comparison

SHPH vs ORIS Comparison

Compare SHPH & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shuttle Pharmaceuticals Holdings Inc.

SHPH

Shuttle Pharmaceuticals Holdings Inc.

HOLD

Current Price

$0.70

Market Cap

3.1M

Sector

Health Care

ML Signal

HOLD

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$0.61

Market Cap

3.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHPH
ORIS
Founded
2012
2014
Country
United States
China
Employees
N/A
69
Industry
Biotechnology: Pharmaceutical Preparations
Farming/Seeds/Milling
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
3.1M
3.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
SHPH
ORIS
Price
$0.70
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
133.1K
1.4M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$152.96
Revenue Growth
N/A
N/A
52 Week Low
$0.12
$0.06
52 Week High
$5.59
$1.87

Technical Indicators

Market Signals
Indicator
SHPH
ORIS
Relative Strength Index (RSI) 37.73 40.33
Support Level $0.50 $0.11
Resistance Level $1.06 $1.08
Average True Range (ATR) 0.11 0.14
MACD 0.01 0.01
Stochastic Oscillator 41.68 22.12

Price Performance

Historical Comparison
SHPH
ORIS

About SHPH Shuttle Pharmaceuticals Holdings Inc.

Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

Share on Social Networks: